Saravanan. R, Bharani Pandilla, Vijayageetha. R, Kavitha. M, Ashok. P
Saravanan. R, Bharani Pandilla*, Vijayageetha. R, Kavitha. M, Ashok. P
Department of Pharmaceutical Analysis, C.L Baid Mehta College of Pharmacy, Thoraipakkam, Chennai - 600097.
Volume - 11,
Issue - 1,
Year - 2021
Artesunate (active metabolite dihydroartemisinin) and artesunate-based combination therapy (ACT) is recommended by the World Health Organization (WHO) for the treatment of severe and multidrug resistant malaria. In the pharmaceutical industry, analytical method development gives important information of drugs potency, bioavailability and its stability. Analytical method development is required for assuring the quality of product. So far, around thirty three analytical methods have been reported for various studies on analysis of artesunate in bulk, pharmaceutical formulations and biological fluids. This review highlights different analytical methods such as chromatography, spectroscopy and hyphenated techniques of artesunate. These techniques are either explored for the quantification, detection of metabolite and also for stability-studies of the artesunate. The present studies revealed that HPLC techniques along with spectroscopic have been most widely explored for the analysis. The brief review may provide information to the researchers who are working in the area of analytical research of artesunate.
Cite this article:
Saravanan. R, Bharani Pandilla, Vijayageetha. R, Kavitha. M, Ashok. P. Recent research on Analytical methods of Analysis of Artesunate: A Review. Asian J. Pharm. Ana. 2021; 11(1): 49-53 doi: 10.5958/2231-5675.2021.00010.
Saravanan. R, Bharani Pandilla, Vijayageetha. R, Kavitha. M, Ashok. P. Recent research on Analytical methods of Analysis of Artesunate: A Review. Asian J. Pharm. Ana. 2021; 11(1): 49-53 doi: 10.5958/2231-5675.2021.00010. Available on: https://ajpaonline.com/AbstractView.aspx?PID=2021-11-1-10
1. Attaran, A., K.I. Barnes, C. Curtis, U. D'Alessandro and C.I. Fanello et al., WHO, the global fund and medical malpractice in malaria treatment. Lancet, 2004; 363:237–40.
2. Miller and B. Greenwood Malaria: A shadow over Africa. Science, 2002; 298: 121-2.
3. Sachs, J.D., A new global efforts to control Malaria. Science, 2002; 298: 122-3.
4. Wellems, T.E., Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Science, 2002; 298: 124-126
5. T.T. Hien and N.J. White. Qinghaosu. Lancet 1993; 341:603-608
6. The International Pharmacopoeia, (3rd ed.) vol.5 2003 222-228 WHO, Geneva.
7. Sunkara Mrunal Chaithanya, Mukthinuthalapati Mathrusri Annapurna. Method Development and Validation of a new RP-HPLC method for the simultaneous Assay of Ketorolac Tromethamine and Fluorometholone. Research J. Pharm. and Tech 2018; 11(7): 3119-3122.
8. Richa A. Dayaramani, Paresh U. Patel, N. J. Patel. Development and Validation of RP-HPLC Method for Estimation of Stavudine in Bulk and in Capsule Formulation. Research J. Pharm. and Tech. 2020; 13(1):15-21.
9. Kiran S Avadhani, Muthukumar Amirthalingam, Meka Sreenivasa Reddy, Nayanabhirama Udupa, Srinivas Mutalik. Development and Validation of RP-HPLC Method for Estimation of Epigallocatechin -3-gallate (EGCG) in Lipid based Nanoformulations. Research J. Pharm. and Tech. 2016; 9(6):725-730
10. Odedara M.H et al. RP-HPLC Method for simultaneous estimation of Artesunate and Amodiaquine HCL in their combined pharmaceutical dosage form. J. Pharn. Sci. and Biotech. Res. 2012; 2(3): 114-117.
11. Uzondu Akueyinwa Lovet Esther and Okafo Sinodukoo Eziuzo. Comparative assessment of the quality of some commercial brands of Artesunate and Amodiaquine antimalarial combination drugs in the Nigerian Market. World Journal of Pharm. Research. 2016; 5(4): 275-291.
12. Fernando Henrique Andrade Nogueira et al. Development and validation of an HPLC method for the simultaneous determination of artesunate and mefloquine hydrochloride in fixed-dose combination tablets. Braz. J. Pharm. Sci. 2013; 49(4): 837-843.
13. S. Jain et al. Selective High Performance Liquid Chromatographic determination of Amodiaquine and Artesunate in bulk and pharmaceutical Formulation. J. of App. Pharma. Sci. 2013; 3(3): 066-070.
14. S. S. Ranher et al. A Validated HPLC method for Determination of Artesunate in bulk and tablet formulation. J. of Ana. Chem. 2010; 65(5): 522-524.
15. Védaste Habyalimana et al. Simple LC Isocratic Method development, validation, and application in the analysis of poor quality antimalarial medicines. American J. of Ana. Chem. 2017; 8: 582-603.
16. Joanne Gartland et al. Analysis of Artesunate and Dihydroartemisinin Using a Core Enhanced Technology. Accucore HPLC Column. Thermo Scientific.
17. Joanne Gartland et al. Analysis of Artesunate and Dihydroartemisinin Using a Syncronis C18 HPLC Column. Thermo Scientific.
18. Manisha Phadke et al. A report on forced degradation studies of artesunate and amodiquine tablets. Ana. Chem. An In. J. 2008; 7(12): 857-861.
19. Padmanabh Deshpande et al. A simple and sensitive RP-HPLC method for simultaneous estimation of Artesunate and Amodiaquine in combined tablet dosage form. J. Chem. Pharm. Res. 2010; 2(6): 429-434.
20. P Raja Rao et al. Analytical method development and validation of Artesunate and Amodiaquine hydrochloride in tablet dosage form by RP-HPLC. In. J. of Res. in Pharmacy and Biotec. 2013; 1(3): 822-827.
21. Patidar Khushwant et al. Analytical Method Development and validation of Artesunate in Bulk and Pharmaceutical Dosage Form by using RP-UPLC with Evaporative Light Scattering Detector. J. Pharm. Sci. and Bioscientific Res. 2016; 6(1): 111-119.
22. P. Jyothi et al. Stability Indicating Method Development and validation for simultaneous estimation of Mefloquine and Artesunate in tablet dosage form. Scho. Aca. J. of Pharmacy. 2014; 3(5): 411-417.
23. S. M. Sandhya et al. Application of HPTLC-densitometry by derivatization and stability Indicating LC for simultaneous determination of Mefloquine Hydrochloride and Artesunate in Combined Dosage form. Amer. Chem. Sci. J. 2015; 7(1): 26-37.
24. Emmanuel Etim et al. Development and validation of UV spectrophotometric method for the determination of artesunate and dihydroartemisinin by coupling. The Pharma Innovation J. 2016; 5(8): 04-07.
25. T. M. Kalyankar et al. Simultaneous Spectrophotometric Estimation of Artesunate and Mefloquine. J. of Chem. 2013; 01-05.
26. Kushwaha Ragini et al. Spectrophotometric Method Determination of Artesunate and Amodiaquine in Combined Dosage Form. Int. J. of R. and Ana. 2018; 5(4): 781-786.
27. C.O. Esimone et al. Evidence for the spectroscopic determination of Artesunate in dosage form. J Vector Borne Dis. 2008; 45: 281-286.
28. Fateh AL Rahman Magbool and Mahmoud ElAoud Ibrahim. Analytical Method Development, Validation and Determination of Artesunate in Pharmaceutical tablet formulations. W. J. of Pharm. and Life Sci. 2018; 4(2): 01-07.
29. Chinyere Okwelogu et al. Development of a simple UV Assay method for Artesunate in pharmaceutical formulations. J Chem. and Pharm Res. 2011; 3(3): 277-285.
30. Sarvesh Sharma et al. Development of Spectrophotometric methods for simultaneous determination of Artesunate and Curcumin in Liposomal formulation. Int. J. of App. Pharm. 2015; 7(1): 18-21.
31. Attih E. E. et al. Rapid titrimetric and Spectrophotometric methods for the determination of Artesunate in bulk and tablet formulations. J Chem Pharm Res 2015; 7(9): 433-442.
32. Akshay D. Sapakal et al. Development and validation of UV-Method for simultaneous estimation of Artesunate and Mefloquine hydrochloride in bulk and marketed formulation. Sch. Acad. J. Pharm. 2013; 2(4): 293-297.
33. Thekke Veettil Sreevidya and Badiadka Narayana. A Simple and Rapid Spectrophotometric method for the determination of Artesunate in pharmaceuticals. Eur. J. of Ana. Chemistry. 2009; 4(1): 119-126.
34. Olajire A. Adegoke and Afolake O. Osoye. Derivatization of Artesunate and Dihydroartemisinin for Colorimetric analysis using p-dimethylaminobenzaldehyde. Eur. J. of Ana. Chemistry. 2011; 6(2): 104-113.
35. R. A. Mahgoub et al. Establishment of Simple Colorimetric Method of Analysis Artesunate in Tablets. J. of Pharm. and Bio. Sci. 2015; 10(5): 51-57.
36. Lawal, A et al. FTIR and UV-Visible spectrophotometeric analyses of artemisinin and its derivatives. J. of Pharm. and Biomed. Sci. 2012; 24(24): 6-14.
37. G. O. Adewuyi et al. Development and validation of a thin layer chromatographic method for the determination of artesunate and amodiaquine in tablet formulations. Afr. J. of Biotech. 2011; 10(60): 13028-13038.
38. Stijin A.A. Van Quekelberghe et al. Optimization of an LC-MS Method for the determination of artesunate and dihydroartemisinin plasma levels using Liquid-Liquid Extraction. J. of Ana. Tox. 2008; 32: 133-139.
39. Breno M. Marson et al. Simultaneous determination of antimalarial Agents by LC-MS/MS and its application to evaluation of fixed-dose tablets. J. Braz. Chem. Soc. 2017; 28(4): 615-621.
40. Yun Liu et al. A replicate designed bioequivalence study to compare two fixed-dose combination products of artesunate and amodiaquine in healthy chinese volunteers. Antimicrob. Agents Chemother. 2014; 58(10): 6009-6015.
41. Niklas Lindegardh et al. Quantification of dihydroartemisinin, artesunate and artemisinin in human blood: overcoming the technical challenge of protecting the peroxide bridge. Bioanalysis. 2011; 3(14): 1613–1624.
42. David A. Godin. Development of an UFLC/MS/MSmethod for the comparative analysis of oxytocin and Artesunate-amodiaquine for validation of field detection systems. Boston University Theses & Dissertations. 2016.
43. Paktiya Teja-Isavadharm et al. A Simplified Liquid Chromatography-Mass Spectrometry assay for Artesunate and Dihydroartemisinin, its Metabolite, in human plasma. Molecules. 2010; 15: 8747-8768.